The Latest Breaking News from StockNews.com

In its most recent quarter, Micron Technology (MU) broke a five-quarter streak of revenue declines, signaling a much-awaited positive growth. However, it also observed a waning in cash reserves. With this mixed performance, is it wise to invest in MU before its second-quarter earnings release? Let's find out….

Even amid hurdles like declining sales and a gloomy outlook, powerhouse athleisure brand Nike (NKE) is forging ahead with cost-cutting strategies. As it prepares to release its third-quarter earnings report, let us assess whether the stock merits a spot in your portfolio.

Fueled by the ever-growing demand for advanced technological solutions across various sectors and ongoing innovation, the tech industry has robust growth prospects. Thus, it could be wise to invest in top tech stocks Dropbox (DBX), TTM Technologies (TTMI), Lantronix (LTRX) and AstroNova (ALOT) for potential growth. Continue reading….

HealthEquity (HQY), the United States’ largest health savings account (HSA) custodian, will release its fourth-quarter results on March 19. The company is expected to report a year-over-year rise in earnings and revenue. Therefore, should investors consider buying the stock ahead of its earnings? Read on to learn my view.

The software industry is thriving with soaring demand, presenting ample investment opportunities. So, fundamentally solid software stocks ServiceNow (NOW), Autodesk (ADSK), and Docebo (DCBO) might be ideal buys for promising returns. Read on.

Despite facing several challenges, the biotech sector thrives due to growing demand for effective treatments, consistent innovations, and a sustained demand for high-quality drugs and therapies. Let's assess whether one should Buy, Hold, or Sell biotech stocks Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR). Keep reading.

The S&P 500 (SPY) has been on a tear since November 1st when the Fed started to make their dovish tilt opening the door to future rate cuts. Unfortunately they keep not happening and start date keeps getting pushed further and further out. That has many wondering if stocks are…

The software market is expanding, driven by increased business spending fueling market demand for software companies. Given this backdrop, let’s analyze whether software stocks C3.ai (AI) and Microsoft Corporation (MSFT) are worth considering for long-term investment now. Read on….

The biotech industry’s growth prospects look promising due to innovative drugs and therapies, government initiatives, and technological advancements. Therefore, investors could consider buying fundamentally strong biotech stocks BioMarin Pharmaceutical (BMRN), Illumina (ILMN), and Harmony Biosciences (HRMY). These stocks are B-rated (Buy) in our proprietary rating system. Read on.